Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of injectable HRS-8427 for complicated urinary tract infection including acute pyelonephritis
CTR20243198Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-8427 in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Hengrui Therapeutics. Started Sep 2024; status: completed.
02
Drugs
HRS-8427
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20243198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243198.